15.82
price down icon3.18%   -0.52
after-market Dopo l'orario di chiusura: 18.04 2.22 +14.03%
loading

Kalvista Pharmaceuticals Inc Azioni (KALV) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
28.16%
55.03
42.94 45.81 44.22 48.45
Operating Income/Loss
28.16%
-55.03
-42.94 -45.81 -44.22 -48.45
Nonoperating Income/Loss
247.43%
1.949
-1.322 3.543 3.772 3.806
Income/Loss From Continuing Operations Before Tax
19.92%
-53.08
-44.26 -42.27 -40.44 -44.65
Income Tax Expense/Benefit
120.13%
-0.855
4.247 - - -
Income/Loss From Continuing Operations After Tax
7.66%
-52.23
-48.51 -42.27 -40.44 -44.65
Net Income/Loss
7.66%
-52.23
-48.51 -42.27 -40.44 -44.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
97.85%
1.1305
52.64 46.70 46.23 2.2187
Diluted Average Shares
97.85%
1.1305
52.64 46.70 46.23 2.2187
Basic Earnings Per Share
7.61%
-0.99
-0.92 -0.91 -0.87 -1.07
Diluted Earnings Per Share
7.61%
-0.99
-0.92 -0.91 -0.87 -1.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.63
price down icon 0.80%
$107.39
price up icon 4.56%
$105.92
price down icon 4.21%
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
$170.27
price down icon 3.26%
Capitalizzazione:     |  Volume (24 ore):